Investor FAQ

To assist shareholders, answers to frequently asked questions are provided below.

Important Notice: The information provided below as answers to frequently asked questions does not take into account your individual investment objectives, financial situation, or needs. The information provided is of a general nature, does not constitute financial advice, and should not be relied upon as the sole basis for any investment decision. Shareholders should contact their financial, legal, and/or tax advisors before deciding to purchase or sell CDIs of REVA.

Expand All
What is REVA’s ticker symbol and on what exchange does it trade?
REVA trades on the Australian Securities Exchange (“ASX”) under the symbol RVA. Our securities trade in the form of CHESS Depositary Interests (CDI’s). REVA’s international ticker symbol is RVA.AX.

REVA also trades on the US OTC market under the symbol RVALL.
Where is REVA headquartered?
REVA’s principal executive offices and manufacturing facilities are located at:

5751 Copley Drive
San Diego, CA 92111
USA
T: (858) 966-3000
T: (800) 583-REVA (583-7382)
F: (858) 966-3099
E: info@revamedical.com
Investor Relations inquiries: ir@revamedical.com
Where is REVA incorporated?
REVA was founded in 1998 and incorporated in California, USA. In 2010, we reincorporated in Delaware, USA. REVA’s headquarters are located in San Diego, California USA.
When does REVA’s fiscal year end?
REVA operates on a December 31 fiscal year end.
Who is REVA’s independent auditor?
The Company’s independent auditor is Grant Thornton LLP.
Who is REVA’s transfer agent and how does one contact them?
The Company’s transfer agent is Computershare. They can be contacted directly via phone at the numbers below:

Regarding CDI positions from within Australia: 1300 855 080
Regarding CDI positions from outside Australia: +61 3 9415 4000
Regarding common stock positions from within the United States: (800) 962-4284
Regarding common stock positions from outside the United States: 1 (781) 575-3120

Shareholders can also access their personal details on Computershare’s websites at:
US: https://www-us.computershare.com/investor
Australia: https://www-au.computershare.com/Investor
What are REVA’s CUSIP and ISIN numbers?
REVA’s CUSIP number is 76133E109 and its ISIN is AU000000RVA3.
How can I get stock prices for REVA?
Historical and current stock prices of CDIs in Australian dollars may be accessed via the ASX website (http://www.asx.com.au/). To calculate the stock price of one share of common stock in US dollars, multiply the price of one CDI by 10 and then multiply by the exchange rate of Australian dollars to US dollars. As an example: A$0.66 per CDI x 10 = A$6.60 x exchange rate of .76 = $5.01 per share of common stock.
Does REVA issue quarterly reports?
REVA files quarterly cash reports and half yearly annual financial reports with the ASX. Additionally, REVA files quarterly and annual financial statements with the US Securities and Exchange Commission (SEC). Filings can be accessed via the ASX Announcements and SEC Filings links on the Investor Relations section of the Company website.
How can I contact someone at REVA with a question or request?
Please feel free to contact us using any of the methods below.

5751 Copley Drive
San Diego, CA 92111
USA
T: (858) 966-3000
T: (800) 583-REVA (583-7382)
F: (858) 966-3099
E: info@revamedical.com
Investor Relations inquiries: ir@revamedical.com
How can I be placed on the REVA email news distribution list?
Please visit the Investor Relations section of the Company website (ir.teamreva.com) and select “Sign up for Email Alerts” at the bottom of the page.